Annual Meeting Archives
2016
Design and in vitro evaluation of a gentamicin-containing hydrogel-forming microneedle patch intended to treat neonatal sepsis
Category:
Transdermal Delivery
Institutions:
(1) Queen's University Belfast, United Kingdom
Design and Validation of an Intraocular In Vitro Simulator
Category:
Comparative Pharmacokinetics in Preclinical Sciences
Institutions:
(1) University of California at San Diego, U.S.A.
Design of a vaginal thin film for extended release of an antiretroviral drug for HIV prevention
Category:
Local Drug Delivery
Institutions:
(1) University of Pittsburgh, U.S.A.
Design of experiments for optimisation of droplet size and non-invasive imaging techniques to study its effect on film coat quality
Category:
Integration of Imaging and Drug Delivery
Institutions:
(1) Aston University, United Kingdom
Design of lipid nanoparticle delivery systems to enable therapeutic applications of siRNA and mRNA
Category:
Oligonucleotide Delivery: New Applications and Opportunities
Institutions:
(1) University of BC, Canada
Designed protein therapeutics for enhancing anti-tumor immune response
Category:
Physical Oncology: Modulating Tumor Microenvironment for Drug Delivery
Institutions:
(1) Korea Institute of Science and Technology, South Korea; (2) Korea Institute of Science and Technology & Korea University, South Korea; (3) Korea Institute of Science and Technology & Seoul National University, South Korea
Developing a Stable Aqueous Enteric Coating Formulation with Hydroxypropyl Methylcellulose Acetate Succinate
Category:
Oral Delivery
Institutions:
(1) University of Maryland, Baltimore, U.S.A.; (2) SE Tylose USA, Inc., U.S.A.
Developing Analytical Methods for In Vitro Comparative Nasogastric (NG) Tube Studies of Esomeprazole Magnesium Delayed Release Capsules
Category:
Oral Delivery
Institutions:
(1) US FDA, U.S.A.
Development and Characterization of Bendamustrine-Dendrimer Conjugates for the Improved Stability and Efficacy
Category:
Local Drug Delivery
Institutions:
(1) Department of Pharmacy, Central University of Rajasthan, India; (2) Central University of Rajasthan, India
Development and characterization of Nintedanib loaded PLGA nanoparticles for improved efficacy against pulmonary fibrosis
Category:
Oral Delivery
Institutions:
(1) Keck Graduate Institute, U.S.A.; (2) Keck Sciences Department of Claremont McKenna, Pitzer, and Scripps Colleges, U.S.A.
Development and Evaluation a Novel Drug Delivery Carrier for Anticancer Therapy
Category:
New Processes, New Materials, New Products
Institutions:
(1) University of South Australia, Australia
Development and Optimization of PLGA Nanoparticles as a Carrier System for Oral Delivery of Gemcitabine to Treat Breast Cancer
Category:
Oral Delivery
Institutions:
(1) School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, New Zealand
Development of a 24-hour Naproxen Sodium Extended Release Tablet
Category:
Oral Delivery
Institutions:
(1) Bayer HealthCare LLC, U.S.A.
Development of a Freeze-dried Lipid-stabilized Nanobubble for Ultrasound Imaging and Gene Delivery
Category:
Integration of Imaging and Drug Delivery
Institutions:
(1) Teikyo University, Japan
Development of a gastro-resistant (GR) formulation of a weak basic drug and evaluation of its pharmacokinetic (PK) impact
Category:
Oral Delivery
Institutions:
(1) BIAL - Portela & Cª., S.A., Portugal
Development of a liposomal formulation for the dermal delivery of active agents
Category:
Transdermal Delivery
Institutions:
(1) Aston University, United Kingdom
Development of a metal tungstate-based nanoparticle platform for CT-guided chemotherapy
Category:
Integration of Imaging and Drug Delivery
Institutions:
(1) Purdue University, U.S.A.
Development of a multiparticulate system for colonic delivery of a model protein Bovine Serum Albumin (BSA)
Category:
Oral Delivery
Institutions:
(1) University of Maryland Baltimore, U.S.A.
Development of a novel in vitro release test method for a polymeric micelle formulation for paclitaxel, Genexol®-PM
Category:
Manufacture, Characterization, Stability, and Regulatory Aspects
Institutions:
(1) Samyang Biopharmaceuticals Corporation, Korea
Development of a reverse phase Waters HPLC method and solid state engineering and characterisation of co-enzyme Q10 using supercritical carbon dioxide
Category:
Encapsulation and Controlled Release for Industrial Applications
Institutions:
(1) School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, New Zealand
Development of an Enema Formulation for Rectal Administration of Magnesium Ions
Category:
Local Drug Delivery
Institutions:
(1) PATH, U.S.A.
Development of an in silico Model for Estimation of Regional Absorption in Lower Gut for Oral Controlled-Release Formulations
Category:
Oligonucleotide Delivery: New Applications and Opportunities
Institutions:
(1) Biopharmaceutics, Pharmaceutical Sciences and Clinical Supply, Merck & Co., U.S.A.; (2) Division of Pharmaceutical Sciences, Long Island University, U.S.A.
Development of Coenzyme Q10 Nano-Emulsions for a Nebulization Delivery
Category:
Local Drug Delivery
Institutions:
(1) University of New Mexico College of Pharmacy, U.S.A.
Development of controlled release Fingolimod by means of an injectable PHBV nanoparticles-Grafted alginate hybrid system
Category:
Encapsulation and Controlled Release for Industrial Applications
Institutions:
(1) Department of Pharmaceutics, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Ira, Iran; (2) Ardebil University of medical science, Ardebil, Iran, Iran
Development of hollow encapsulin nanoparticles for the incorporation of hydrophilic compounds
Category:
Peptides, Proteins, and Vaccines
Institutions:
(1) Tokyo University of Agriculture and Technology, Japan